Back

Efficacy comparison of transcatheter aorticorenal ganglion ablation and renal denervation in a hypertensive canine model

30 August 2024 (08:51 - 09:09)
Organised by: Logo
Congress Presentation Part of: Device-based hypertension therapies: third pillar in hypertension management? Device Treatment and Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yuxiang Long

Chongqing (China)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on device-based hypertension management
Professor I. Sudano (Zurich, CH)
Slides Video
Presentation thumbnail
Blood pressure and renal function changes in patients with severe chronic kidney disease undergoing radiofrequency renal denervation: 12 months outcomes from the Global SYMPLICITY Registry DEFINE
Professor M. Schlaich (Perth, AU)
Abstract Slides Video
Presentation thumbnail
Nighttime blood pressure reductions after radiofrequency renal denervation through 24 months in patients with uncontrolled hypertension: pooled analysis from the SPYRAL HTN trials
Professor K. Tsioufis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
The relationship between lung MIBG uptake and clinical response to renal denervation
Doctor H. Dalpiaz (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Device-based hypertension therapies: third pillar in hypertension management?
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 08:51 CET
You may be interested in
thumbnail
Congress Presentation
Effect of selective renal denervation guided by renal nerve stimulation on atrial remodeling
thumbnail
Congress Session
Device-based hypertension therapies: third pillar in hypertension management?
thumbnail
Congress Presentation
Hot papers on device-based treatment of hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources